サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1771630

米国の造影剤注入器市場規模、シェア、動向分析レポート：製品別、最終用途別、タイプ別、セグメント予測、2025年～2030年

U.S. Contrast Media Injectors Market Size, Share & Trends Analysis Report By Product (Injector Systems, Consumables), By Application (Radiology, Interventional Cardiology), By Type, By End Use, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 110 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
米国の造影剤注入器市場規模、シェア、動向分析レポート：製品別、最終用途別、タイプ別、セグメント予測、2025年～2030年
出版日: 2025年06月11日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の造影剤注入器市場動向：

米国の造影剤注入器市場規模は2024年に6億494万米ドルと推計され、2025年から2030年にかけてCAGR 10.08％で成長すると予測されています。

市場成長の背景には、がん、心血管疾患、神経疾患などの慢性疾患の罹患率の上昇があります。慢性疾患の増加は、CTスキャンやMRIのような高度な画像診断技術とともに、X線や超音波のような従来の画像診断法を使用する画像診断検査の需要を促進しています。

北米の造影剤注入器産業は、MRI、CTスキャン、心血管造影などの画像診断の需要増に牽引され、大幅な成長が見込まれています。この急成長の背景には、画像技術の進歩、高齢化、予防ヘルスケアに対する意識の高まり、慢性疾患の蔓延などがあります。医療用画像診断は、様々な疾患の早期発見、診断、治療計画において極めて重要です。国立医学図書館が2023年10月に発表した研究によると、米国では年間約4,000万件のMRI検査が行われています。

さらに、2024年2月にCDCが発表したデータによると、約1億2,900万人の米国人が少なくとも1つの主要な慢性疾患を抱えて生活していることが明らかになりました。このような慢性疾患の大きな負担と、毎年実施される大量の画像検査が相まって、画像診断の必要性が強く高まっていることが浮き彫りになり、地域全体の造影剤注入装置の需要をさらに押し上げています。したがって、長期的な疾患と複雑な併存疾患の有病率の増加は、造影剤注入器の需要の増加につながるため、主要なドライバーの1つです。

造影剤注入器の製品発売や規制認可の増加は、市場の成長を大きく促進すると予想されます。企業は、効率と患者の転帰を改善するために、シリンジレス注射器や多人数用注射器などの先進技術を導入しています。これらの技術革新は、業務ワークフローを強化し、より良い画像診断の実践をサポートすることで、高度な画像診断システムの幅広い採用を促しています。その結果、信頼性が高く効果的な造影剤供給ソリューションへの需要が高まり続け、市場の拡大にさらに拍車をかけています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の造影剤注入器市場の変数、動向、範囲

  • 市場系統の見通し
    • 関連/補助的な市場見通し
  • ユーザーの視点分析
    • 消費者行動分析
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 米国の造影剤注入器市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国の造影剤注入器市場：製品推定・動向分析

  • 定義と範囲
  • 製品市場シェア、2018年および2030年
  • セグメントダッシュボード
  • 米国の造影剤注入器市場：製品別展望
  • 2024年から2030年までの市場規模と予測および動向分析
    • インジェクターシステム
    • 消耗品

第5章 米国の造影剤注入器市場：タイプ推定・動向分析

  • 定義と範囲
  • タイプ別市場シェア、2018年と2030年
  • セグメントダッシュボード
  • 米国の造影剤注入器市場：タイプ別展望
  • 2024年から2030年までの市場規模と予測および動向分析
    • シングルヘッドインジェクター
    • デュアルヘッドインジェクター
    • シリンジレスインジェクター

第6章 米国の造影剤注入器市場：用途の推定・動向分析

  • 定義と範囲
  • 用途市場シェア、2018年および2030年
  • セグメントダッシュボード
  • 米国の造影剤注入器市場：用途別展望
  • 2024年から2030年までの市場規模と予測および動向分析
    • 放射線科
    • インターベンショナルカーディオロジー
    • インターベンショナルラジオロジー

第7章 米国の造影剤注入器市場：最終用途の推定・動向分析

  • 定義と範囲
  • 最終用途市場シェア、2018年および2030年
  • セグメントダッシュボード
  • 米国の造影剤インジェクター市場：最終用途別展望
  • 2024年から2030年までの市場規模と予測および動向分析
    • 病院
    • 診断センター
    • 外来手術センター

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
    • イノベーター
  • ベンダー情勢
    • 主要販売代理店およびチャネルパートナーのリスト
    • Key customers
    • Key company market share analysis, 2024
    • Shenzhen Boon Medical Supply Co., Ltd.
    • Bracco Diagnostics Inc.
    • Bayer
    • Guerbet
    • ulrich GmbH &Co. KG
    • B.Braun SE
    • Shenzhen Antmed Co., Ltd.
    • Ecomed Solutions
    • Siemens Medical Solutions USA, Inc.（Siemens Healthineers AG）
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. contrast media injectors market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. contrast media injectors market, by type, 2018 - 2030 (USD Million)
  • Table 5 U.S. contrast media injectors market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. contrast media injectors market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Contrast media injectors market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Segment outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Consumer behavior analysis
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's Five Forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 U.S. Contrast media injectors market: Product movement analysis
  • Fig. 19 U.S. Contrast media injectors market: Product Segment dashboard
  • Fig. 20 U.S. Contrast media injectors market product outlook: Key takeaways
  • Fig. 21 U.S. Injector systems market, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. CT injector systems market, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. MRI injector systems market, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Cardiovascular/angiography injector systems market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Consumables market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Syringes market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Tubings market, 2018 - 2030 (USD Million)
  • Fig. 28 Others market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Contrast media injectors market: Type movement analysis
  • Fig. 30 U.S. Contrast media injectors market: Type Segment dashboard
  • Fig. 31 U.S. Contrast media injectors market type outlook: Key takeaways
  • Fig. 32 U.S. Single head injectors market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Dual head injectors market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Syringeless injectors market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Contrast media injectors market: Application movement analysis
  • Fig. 36 U.S. Contrast media injectors market: Application Segment dashboard
  • Fig. 37 U.S. Contrast media injectors market application outlook: Key takeaways
  • Fig. 38 U.S. Radiology market, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Interventional cardiology market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Interventional radiology market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Contrast media injectors market: End use movement analysis
  • Fig. 42 U.S. Contrast media injectors market: End use Segment dashboard
  • Fig. 43 U.S. Contrast media injectors market end use outlook: Key takeaways
  • Fig. 44 U.S. Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. Diagnostics centres market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Ambulatory surgery centers market, 2018 - 2030 (USD Million)
  • Fig. 47 Company market share analysis, 2024
  • Fig. 48 Market differentiators
目次
Product Code: GVR-4-68040-231-5

U.S. Contrast Media Injectors Market Trends:

The U.S. contrast media injectors market size was estimated at USD 604.94 million in 2024 and is projected to grow at a CAGR of 10.08% from 2025 to 2030. The market growth is attributed to the rising incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders. The rising number of chronic diseases is driving the demand for diagnostic imaging tests that use conventional imaging methods such as X-rays and ultrasounds, along with advanced imaging techniques such as CT scans and MRIs.

The North America contrast media injectors industry is expected to grow significantly, driven by the rising demand for imaging procedures such as MRI, CT scans, and cardiovascular angiography. This surge is fueled by advancements in imaging technology, an aging population, increasing awareness of preventive healthcare, and the growing prevalence of chronic diseases. Medical imaging is critical in early detection, diagnosis, and treatment planning for a wide range of conditions. According to a study published by the National Library of Medicine in October 2023, nearly 40 million MRI scans are performed annually in the U.S.

In addition, data from the CDC in February 2024 revealed that approximately 129 million Americans are living with at least one major chronic illness. This substantial burden of chronic disease, combined with the high volume of imaging tests performed each year, highlights a strong and growing need for diagnostic imaging, further driving demand for contrast media injectors across the region. Hence, the increasing prevalence of long-term diseases and complex comorbidities is one of the major drivers, as it is leading to an increase in demand for contrast media injectors.

The growing number of product launches and regulatory approvals for contrast media injectors is expected to drive market growth significantly. Companies are introducing advanced technologies, including syringeless and multi-patient injectors, to improve efficiency and patient outcomes. These innovations enhance operational workflows and support better imaging practices, encouraging broader adoption of advanced imaging systems. As a result, the demand for reliable and effective contrast media delivery solutions continues to rise, further fueling market expansion.

U.S. Contrast Media Injectors Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. contrast media injectors market report based on product, type, application, and end use:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Injector Systems
    • CT injector systems
    • MRI injector systems
    • Cardiovascular/angiography injector systems
  • Consumables
    • Tubing
    • Syringe
    • Others
  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Single Head Injectors
  • Dual-Head Injectors
  • Syringeless Injectors
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Radiology
  • Interventional Cardiology
  • Interventional Radiology
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Diagnostics Centers
  • Ambulatory Surgery Centers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Third Party Perspective
    • 1.3.5. Primary research
    • 1.3.6. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights Outlook

Chapter 3. U.S. Contrast Media Injectors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Related/ancillary market outlook.
  • 3.2. User Perspective Analysis
    • 3.2.1. Consumer behavior analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing demand for imaging tests
      • 3.3.1.2. Rising launches and approvals of contrast media injectors
      • 3.3.1.3. Increasing prevalence of chronic disorders
      • 3.3.1.4. Growing adoption of syringe less injectors
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Potential complications and risks associated with contrast media injections
    • 3.3.3. Market opportunity analysis
      • 3.3.3.1. Rising number of distribution agreements
      • 3.3.3.2. Advancements in contrast media injectors
      • 3.3.3.3. Growing clinical trials for contrast media and injectors
    • 3.3.4. Market challenge analysis
      • 3.3.4.1. Shortage of radiologists and healthcare professionals
  • 3.4. U.S. Contrast Media Injectors Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. U.S. Contrast Media Injectors Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Product Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. U.S. Contrast Media Injectors Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 4.5.1. Injector Systems
      • 4.5.1.1. Injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.2. CT injector systems
        • 4.5.1.2.1. CT injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.3. MRI injector systems
        • 4.5.1.3.1. MRI injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.4. Cardiovascular/angiography injector systems
        • 4.5.1.4.1. Cardiovascular/angiography injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Consumables
      • 4.5.2.1. Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.2. Syringes
        • 4.5.2.2.1. Syringes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.3. Tubings
        • 4.5.2.3.1. Tubings market revenue estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.4. Others
        • 4.5.2.4.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Contrast Media Injectors Market: Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Type Market Share, 2018 & 2030
  • 5.3. Segment Dashboard
  • 5.4. U.S. Contrast Media Injectors Market by Type Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 5.5.1. Single Head Injectors
      • 5.5.1.1. Single head injectors market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Dual Head Injectors
      • 5.5.2.1. Dual head injectors market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Syringeless Injectors
      • 5.5.3.1. Syringeless injectors market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. U.S. Contrast Media Injectors Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Application Market Share, 2018 & 2030
  • 6.3. Segment Dashboard
  • 6.4. U.S. Contrast Media Injectors Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 6.5.1. Radiology
      • 6.5.1.1. Radiology market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Interventional Cardiology
      • 6.5.2.1. Interventional cardiology market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Interventional Radiology
      • 6.5.3.1. Interventional radiology market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. U.S. Contrast Media Injectors Market: End Use Estimates & Trend Analysis

  • 7.1. Definitions and Scope
  • 7.2. End Use Market Share, 2018 & 2030
  • 7.3. Segment Dashboard
  • 7.4. U.S. Contrast Media Injectors Market by End Use Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 7.5.1. Hospitals
      • 7.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.2. Diagnostics Centers
      • 7.5.2.1. Diagnostics centers market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.3. Ambulatory Surgery Centers
      • 7.5.3.1. Ambulatory surgery centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Shenzhen Boon Medical Supply Co., Ltd.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bracco Diagnostics Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Bayer
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Guerbet
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. ulrich GmbH & Co. KG
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. B.Braun SE
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Shenzhen Antmed Co., Ltd.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Ecomed Solutions
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Siemens Medical Solutions USA, Inc. (Siemens Healthineers AG)
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives